("Seaspring"), to advance regulatory approval and commercialization of the Company's sepsis diagnosis technology (SepsetER TM) in the Kingdom of Bahrain and the Middle East and North Africa (MENA). The definitive agreement was signed on June 1, 2023, by Asep Inc.'s CEO, Dr. Robert E. W. Hancock and Seaspring's Founder and Managing Director, Shaikh Isa bin Khalid Al-Khalifa. ABOUT ASEP MEDICAL HOLDINGS INC.Asep Medical Holdings Inc. (asepmedical.com) is dedicated to addressing the global issue of antibiotic failure by developing novel solutions for significant unmet medical needs in human medicine. SafeCoat Medical Inc.'s (safecoatmedical.com) technology encompasses self-assembling polymers combined with conjugated antimicrobial peptides, which can be applied to various surfaces as antimicrobial and anti-fouling coatings. SOURCE ASEP Medical Holdings Inc.

Source: The North Africa Journal June 09, 2023 23:16 UTC